Streptococcus pneumoniae type 14 capsular polysaccharide antigen
- Generic Name
- Streptococcus pneumoniae type 14 capsular polysaccharide antigen
- Brand Names
- Pneumovax 23, Prevnar 13, Vaxneuvance, Synflorix
- Drug Type
- Biotech
- Unique Ingredient Identifier
- G1GFK9898U
Overview
Streptococcus pneumoniae type 14 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 14 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Background
Streptococcus pneumoniae type 14 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 14 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Indication
No indication information available.
Associated Conditions
- Pneumococcal Infection
- Streptococcus Pneumoniae Infections
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|---|---|---|---|---|---|---|---|
EMEA/H/C/001104 | Belgium | N/A | Authorised | 2009/12/09 | 2009/09/24 | 49 | ||
EMEA/H/C/000973 | Belgium | N/A | Authorised | 2009/03/29 | N/A | 36 | ||
EMEA/H/C/005451 | Belgium | Monitoring | Authorised | 2022/02/14 | 2021/12/16 | 11 | ||
EMEA/H/C/005451 | Belgium | Monitoring | Authorised | 2022/02/14 | 2021/12/16 | 11 | ||
EMEA/H/C/005451 | Belgium | Monitoring | Authorised | 2022/02/14 | 2021/12/16 | 11 | ||
EMEA/H/C/005451 | Belgium | Monitoring | Authorised | 2022/02/14 | 2021/12/16 | 11 |
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|---|---|---|---|---|
INJECTION, SUSPENSION | 2.2 μg/0.5ml | 2022/11/30 | SIN16648P | ||
INJECTION, SUSPENSION | 2.2mcg | 2010/07/02 | SIN13824P |
NMPA Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|
No NMPA products found
No NMPA products found for this drug
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No TGA products found
No TGA products found for this drug